These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1191942)

  • 1. Serum alpha-1-acid glycoprotein as an index of dissemination in breast cancer.
    Roberts JG; Keyser JW; Baum M
    Br J Surg; 1975 Oct; 62(10):816-9. PubMed ID: 1191942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of preliminary bone scanning in staging and assessing the prognosis of breast cancer.
    Campbell DJ; Banks AJ; Oates GD
    Br J Surg; 1976 Oct; 63(10):811-6. PubMed ID: 990703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective study of first indicators of breast cancer recurrence.
    Pivot X; Asmar L; Hortobagyi GN; Theriault R; Pastorini F; Buzdar A
    Oncology; 2000 Apr; 58(3):185-90. PubMed ID: 10765118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorine 18 bone scans in the detection of early metastatic bone tumors.
    Hopkins GB; Kristensen KA; Blickenstaff DE
    JAMA; 1972 Nov; 222(7):813-4. PubMed ID: 4677932
    [No Abstract]   [Full Text] [Related]  

  • 5. Sensitivity of 18 F bone scans in the search for metastases.
    Sharma SM; Quinn JL
    Surg Gynecol Obstet; 1972 Oct; 135(4):536-40. PubMed ID: 5085991
    [No Abstract]   [Full Text] [Related]  

  • 6. Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancer.
    Allard WJ; Neaman IE; Elting JJ; Barnett TR; Yoshimura H; Fritsche HA; Yeung KK
    Cancer Res; 1994 Mar; 54(5):1227-34. PubMed ID: 8118811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of preoperative bone and liver scans and alkaline phosphatase in the evaluation of breast cancer patients.
    Brar HS; Sisley JF; Johnson RH
    Am J Surg; 1993 Feb; 165(2):221-3; discussion 224. PubMed ID: 8427400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up of patients with localized breast cancer and first indicators of advanced breast cancer recurrence: A retrospective study.
    Viot J; Bachour M; Meurisse A; Pivot X; Fiteni F
    Breast; 2017 Aug; 34():53-57. PubMed ID: 28505557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is an increase in CA 125 in breast cancer patients an indicator of pleural metastases?
    Jäger W; Kissing A; Cilaci S; Melsheimer R; Lang N
    Br J Cancer; 1994 Sep; 70(3):493-5. PubMed ID: 8080736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of serum bone resorption markers in the diagnosis of skeletal metastasis.
    Koizumi M; Takahashi S; Ogata E
    Anticancer Res; 2003; 23(5b):4095-9. PubMed ID: 14666607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone metastases from breast cancer at the time or radical mastectomy as detected by bone scan. Eight-year follow-up.
    Sklaroff RB; Sklaroff DM
    Cancer; 1976 Jul; 38(1):107-11. PubMed ID: 947508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG) in patients with breast, gastric and colorectal cancer.
    Shimizu Y; Oshima K; Nakano Y; Fujita M; Taguchi T
    Biken J; 1981 Sep; 24(3):95-102. PubMed ID: 6175310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of bone scanning and CA 15-3 serum concentration in the follow-up of breast cancer.
    Montravers F; Younsi N; Rousseau C; Philippe C; Seddiki M; Uzan S; Izrael V; Talbot JN
    Anticancer Res; 1997; 17(3B):1683-6. PubMed ID: 9179218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiorgan scans for staging lung cancer. Correlation with clinical evaluation.
    Ramsdell JW; Peters RM; Taylor AT; Alazraki NP; Tisi GM
    J Thorac Cardiovasc Surg; 1977 May; 73(5):653-9. PubMed ID: 850423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated levels of serum tumor markers CA 15-3 and CEA are prognostic factors for diagnosis of metastatic breast cancers.
    Lee JS; Park S; Park JM; Cho JH; Kim SI; Park BW
    Breast Cancer Res Treat; 2013 Oct; 141(3):477-84. PubMed ID: 24072270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bone marrow examination in breast cancer: diagnostic considerations and clinical usefulness.
    Ingle JN; Tormey DC; Tan HK
    Cancer; 1978 Feb; 41(2):670-4. PubMed ID: 630544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen degradation products in serum from patients with cancer.
    Carlsson S
    Acta Chir Scand; 1973; 139(6):499-502. PubMed ID: 4753096
    [No Abstract]   [Full Text] [Related]  

  • 18. Symptomatology as an indicator of recurrent or metastatic breast cancer.
    Winchester DP; Sener SF; Khandekar JD; Oviedo MA; Cunningham MP; Caprini JA; Burkett FE; Scanlon EF
    Cancer; 1979 Mar; 43(3):956-60. PubMed ID: 427736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of neoplasms with incidence and localization of skeletal metastases: An analysis of 1,355 diphosphonate bone scans.
    Tofe AJ; Francis MD; Harvey WJ
    J Nucl Med; 1975 Nov; 16(11):986-9. PubMed ID: 810549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased level of circulating adhesion molecules in the sera of breast cancer patients with distant metastases.
    Matsuura N; Narita T; Mitsuoka C; Kimura N; Kannagi R; Imai T; Funahashi H; Takagi H
    Jpn J Clin Oncol; 1997 Jun; 27(3):135-9. PubMed ID: 9255266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.